Published in J Alzheimers Dis on January 01, 2010
Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement (2012) 1.21
Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol (2011) 1.15
The emerging role of dietary fructose in obesity and cognitive decline. Nutr J (2013) 1.05
Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci (2014) 1.04
Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology (2013) 0.98
Nutrition and prevention of Alzheimer's dementia. Front Aging Neurosci (2014) 0.92
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. Age (Dordr) (2011) 0.92
Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychol Med (2013) 0.91
Cognitive function and the risk of death in chronic kidney disease. Am J Nephrol (2011) 0.88
Effect of leisure activities on inflammation and cognitive function in an aging sample. Arch Gerontol Geriatr (2012) 0.85
Brain lesions, hypertension and cognitive ageing in the 1921 and 1936 Aberdeen birth cohorts. Age (Dordr) (2011) 0.84
High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment. J Alzheimers Dis (2012) 0.82
Cyclooxygenase-derived vasoconstriction restrains hypoxia-mediated cerebral vasodilation in young adults with metabolic syndrome. Am J Physiol Heart Circ Physiol (2013) 0.81
Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS One (2012) 0.81
Physical performance and disability in schizophrenia. Schizophr Res Cogn (2014) 0.79
Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models. Int J Mol Sci (2016) 0.79
Linking cognition and frailty in middle and old age: metabolic syndrome matters. Int J Geriatr Psychiatry (2014) 0.78
Longitudinal effects of metabolic syndrome on Alzheimer and vascular related brain pathology. Dement Geriatr Cogn Dis Extra (2014) 0.78
Longitudinal relationships between subjective fatigue, cognitive function, and everyday functioning in old age. Int Psychogeriatr (2012) 0.78
Modifiable Factors Associated with Cognitive Impairment in 1,143 Japanese Outpatients: The Project in Sado for Total Health (PROST). Dement Geriatr Cogn Dis Extra (2016) 0.77
Genetic modifiers of cognitive maintenance among older adults. Hum Brain Mapp (2014) 0.77
Obesity and age-related alterations in the gene expression of zinc-transporter proteins in the human brain. Transl Psychiatry (2016) 0.76
Association of Metabolic Syndrome and Inflammation with Cognitive Decline in Adults Aged 60 Years and Older: Findings from a National Health Survey in the United States. Neurosci J (2013) 0.75
Evaluation of objective and perceived mental fatigability in older adults with vascular risk. J Psychosom Res (2014) 0.75
Red Raspberries and Their Bioactive Polyphenols: Cardiometabolic and Neuronal Health Links. Adv Nutr (2016) 0.75
Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome. Redox Biol (2017) 0.75
High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex. Transl Psychiatry (2017) 0.75
Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats. Am J Physiol Heart Circ Physiol (2015) 0.75
A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus. J Alzheimers Dis (2016) 0.75
Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder. J Psychiatr Res (2017) 0.75
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol (2007) 4.03
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology (2007) 2.32
Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry (2010) 2.22
An association study between epicardial fat thickness and cognitive impairment in the elderly. Am J Physiol Heart Circ Physiol (2014) 2.06
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease. J Am Geriatr Soc (2008) 2.05
Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience. Ultrasound Med Biol (2008) 1.80
The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol (2008) 1.64
Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry (2005) 1.63
Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res (2008) 1.60
Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol Dial Transplant (2008) 1.57
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res (2004) 1.55
Addition of the multidimensional prognostic index to the estimated glomerular filtration rate improves prediction of long-term all-cause mortality in older patients with chronic kidney disease. Rejuvenation Res (2012) 1.51
Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging (2005) 1.46
Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol (2003) 1.45
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease. Intern Emerg Med (2011) 1.42
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial. Phys Ther (2009) 1.35
High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci (2013) 1.32
Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients. PLoS One (2012) 1.32
Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf (2008) 1.31
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev (2010) 1.30
Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol (2007) 1.28
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy (2012) 1.18
The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimers Dis (2009) 1.16
The multidimensional prognostic index predicts short- and long-term mortality in hospitalized geriatric patients with pneumonia. J Gerontol A Biol Sci Med Sci (2009) 1.15
Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer. Epigenetics (2011) 1.12
Diverticular disease in the elderly. Dig Dis (2007) 1.11
Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology (2004) 1.10
Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. J Biol Chem (2007) 1.08
Fatal systemic venous air embolism during endoscopic retrograde cholangiopancreatography. Adv Anat Pathol (2009) 1.08
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry (2012) 1.08
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion. J Med Chem (2005) 1.07
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimers Dis (2010) 1.06
Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp Gerontol (2005) 1.06
Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother (2008) 1.06
Oxidative stress and aging. J Nephrol (2010) 1.06
Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. Prog Lipid Res (2011) 1.05
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res (2005) 1.05
Mitochondrial involvement in non-alcoholic steatohepatitis. Mol Aspects Med (2007) 1.05
Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet. PLoS One (2011) 1.04
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? Expert Opin Investig Drugs (2011) 1.04
Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett (2003) 1.04
Mitochondrial function in liver disease. Front Biosci (2007) 1.03
Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother (2011) 1.03
Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta (2005) 1.03
Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging (2009) 1.02
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter (2007) 1.01